Quoin Pharmaceuticals (QNRX) Other Accumulated Expenses (2020 - 2026)
Quoin Pharmaceuticals (QNRX) posted Other Accumulated Expenses of $600000.0 for Q1 2026, little changed sequentially from $600000.0 in Q4 2025, and little changed YoY from $600000.0 in Q1 2025.
Quoin Pharmaceuticals (QNRX) Other Accumulated Expenses (2020 - 2026) Analysis & Trends
Quoin Pharmaceuticals has reported Other Accumulated Expenses for 7 years, with the latest figure at $600000.0 in Q1 2026.
- Quarterly Other Accumulated Expenses changed 0.0% year-over-year to $600000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $600000.0 (changed 0.0% YoY) and the FY2025 annual result came in at $600000.0, changed 0.0% from the prior year.
- Other Accumulated Expenses held at $600000.0 in Q1 2026 per QNRX's latest filing, from $600000.0 in the prior quarter.
- Over five years, Other Accumulated Expenses peaked at $725000.0 in Q2 2023 and troughed at $42727.0 in Q2 2022.
- A 5-year average of $509598.4 and a median of $600000.0 in 2022 frame the typical range for Other Accumulated Expenses.
- The sharpest annual moves came in 2022 and 2024: Other Accumulated Expenses soared 9940.16% in 2022, then slipped 17.24% in 2024.
- Over 5 years, Other Accumulated Expenses stood at $600000.0 in 2022, then changed by 0.0% to $600000.0 in 2023, then changed by 0.0% to $600000.0 in 2024, then changed by 0.0% to $600000.0 in 2025, then changed by 0.0% to $600000.0 in 2026.
- According to Business Quant data, Other Accumulated Expenses over the past three periods registered $600000.0, $600000.0, and $600000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Quoin Pharmaceuticals | 531,643.73 | 531,643.73 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 600,000.00 |
| Dec 31, 2025 | 600,000.00 |
| Sep 30, 2025 | 600,000.00 |
| Jun 30, 2025 | 600,000.00 |
| Mar 31, 2025 | 600,000.00 |
| Dec 31, 2024 | 600,000.00 |
| Sep 30, 2024 | 600,000.00 |
| Jun 30, 2024 | 600,000.00 |
| Mar 31, 2024 | 600,000.00 |
| Dec 31, 2023 | 600,000.00 |
| Sep 30, 2023 | 600,000.00 |
| Jun 30, 2023 | 725,000.00 |
| Mar 31, 2023 | 124,626.00 |
| Dec 31, 2022 | 600,000.00 |
| Sep 30, 2022 | 61,222.00 |
| Jun 30, 2022 | 42,727.00 |
| Dec 31, 2021 | 5,976.00 |
| Dec 31, 2020 | 5,802.00 |